Anthony Burgett, Ph.D.

---

Publications & Presentations

1. Dogra S, Adhikari L, Benbrook D M, Bohn J A, Burgett A, Chandra V, Dockery L, Singh A, McNally L, Rai R, Isingizwe Z R, Richardson D L, Yang Z, Hannafon B N. Harnessing ovarian cancer ascites for translational science: models, biomarkers, and therapeutics. Molecular Cancer. 2025; 24

2. Galie W, Bayimenye R F, Burgett A, Bourne C. Visualizing Oxysterol-binding Protein Ligand-Triggered Structural Signals. Structural Dynamics. 2025; 12 : A159-A159

3. Mogire R M, Muriuki J M, Bayimenye R F, Mentzer A J, Chong A, Gouveia M H, Bentley A R, Band G, King’ori P, Mitchell R, Webb E L, Sengupta D, Ekunwe L, Ndungu F M, Morovat A, Macharia A W, Cutland C L, Hemani G, Sirima S B, Ramsay M, Figueiredo C A, Prentice A M, Madhi S A, Raffield L M, Sandhu M S, Bejon P, Smith G D, Elliott A M, Williams T N, Rotimi C, Bourne C R, Burgett A, Adeyemo A, Atkinson S H. OSBPL11 is an African-specific locus associated with 25-hydroxyvitamin D concentrations and cardiometabolic health. openRxiv. 2025

4. Chowdhury T, Cupp-Sutton K A, Guo Y, Gao K, Zhao Z, Burgett A, Wu S. Quantitative Top-down Proteomics Revealed Kinase Inhibitor-Induced Proteoform-Level Changes in Cancer Cells. Journal of Proteome Research. 2025; 24 : 303-314

5. Peng Z, Lan Y, Nimmo S L, Bui R H, Benbrook D M, Burgett A, Yang Z. Mass Spectrometry Quantification of Anticancer Drug Uptake in Single Multicellular Tumor Spheroids. ACS Pharmacology and Translational Science. 2024; 7 : 3011-3016

Grants

6. Single Cancer Cell Mass Spectrometry Technology for the Bioanalysis and Effective Drug Treatment of Ovarian Cancer. Intramural Funding. Start Date: 2022. End Date: 2023.

7. Drug Targeting Oxysterol-Binding Protein (OSBP) for Antiviral Treatment of SARS-CoV-2 Infections. Intramural Funding. Start Date: 2022. End Date: 2023.

8. Drug Targeting Oxysterol-Binding Protein (OSBP) for Antiviral Treatment of SARS-CoV-2 Infections. Misc Non-Federal. Start Date: 2022. End Date: 2023.

9. Acquisition of a Campus Sample Concentrator/Lyophilizer for Drug Development and Pharmacology Research. Non-federal. Start Date: 2022. End Date: 2023.

10. Structure/Function of Oxysterol-Binding Protein to Guide Therapeutic Development. NIH. Start Date: 2022. End Date: 2023.

Awards and Honors

1. C.B. Hudson/Torchmark Foundation Presidential Professorship. Date: 2025.


2. Oklahoma House of Representatives Citation for Commitment to Education and Service in the State of Oklahoma. Date: 2019.


3. University of Oklahoma Faculty Leadership Academy Graduate. Date: 2017.


4. University of Oklahoma. Paul G. Risser Innovative Teaching Fellow . Date: 2015.


5. Susan G. Komen for the Cure Foundation Postdoctoral Fellow. Date: 2007.

Education

1. Degree: Post. Harvard University. Date: 2012.


2. Degree: Ph D. . Date: 2006.


3. Degree: BS. University of Oklahoma. Date: 1999.


4. Degree: BS. University of Oklahoma. Date: 1999.

Administrative Assignments

no results